New Releases from NCBI BookshelfDelgocitinib (Anzupgo): Indication: For the treatment of moderate to severe chronic hand eczema in adults for whom topical corticosteroids are inadequate or are not advisable: Reimbursement Recommendation [Internet].​Delgocitinib (Anzupgo): Indication: For the treatment of moderate to severe chronic hand eczema in adults for whom topical corticosteroids are inadequate or are not advisable: Reimbursement Recommendation [Internet].